Profile
Evonik Venture Capital is the corporate venture arm of Evonik Industries AG, a global specialty chemicals company based in Hanau, Germany. Founded in 2012, the firm focuses on investing in innovative technologies and business models that align with Evonik's strategic interests. The team consists of 8 professionals who leverage their expertise in chemicals and related industries to identify and support promising startups.
The firm primarily invests in Series A rounds, with a focus on sectors such as enterprise applications, high tech, and food and agriculture tech. Evonik Venture Capital has a global investment reach, with a particular emphasis on the United States. The firm manages the Sustainability Tech Fund I, which has an AUM of $150 million, launched in 2022.
Notable investments include Vivasure Medical - medical devices, OPTIFarm - agricultural technology, Synoste - medical devices, Citrine Informatics - materials informatics, and Modern Meadow - biofabrication technology.
Industry
Evonik Venture Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Sustainability Tech Fund I
|
Venture Capital (VC)
|
Chemicals
Fashion/Beauty
Food and Beverage
Foodtech
Gaming
Healthcare Services
Energy
HealthTech
|
Pre-seed
Seed
|
North America
Europe
|
$5-10 m
|
$150 M
|
June 2022
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.